Plaque Psoriasis Efficacy and Safety With Secukinumab

NCT02409667 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
16487
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals